The Bioflavonoid Kaempferol Is an Abcg2 Substrate and Inhibits Abcg2-Mediated Quercetin Efflux

被引:70
作者
An, Guohua [1 ]
Gallegos, Jorge [1 ]
Morris, Marilyn E. [1 ]
机构
[1] SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Amherst, NY 14260 USA
关键词
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN; FLAVONOIDS; APOPTOSIS; CELLS; RATS; TRANSPORTERS; DISPOSITION; PHARMACOKINETICS; ADULTS;
D O I
10.1124/dmd.110.035212
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The flavonoids quercetin and kaempferol are major constituents of Ginkgo biloba extract. The ATP-binding cassette efflux transporter, breast cancer resistance protein (Bcrp, Abcg2), is involved in the transport of quercetin and represents a possible mechanism for the low bioavailability of quercetin. Our objective was to investigate whether kaempferol inhibits Bcrp-mediated quercetin efflux and determine whether it is a substrate for BCRP. The intracellular uptake of kaempferol, with and without specific inhibitors, was determined in Bcrp-expressing cells. The transport of quercetin or kaempferol (10 mu M) across Madin-Darby canine kidney (MDCK) cell monolayers was investigated in both the apical (A)-to-basolateral (B) and B-to-A directions. Samples were analyzed using liquid chromatography-tandem mass spectrometry. Compared with the quercetin alone group, the transport ratio decreased 11.6-fold (from 97.5 to 8.37) in the presence of kaempferol in MDCK/Bcrp1 cells, indicating that kaempferol is a Bcrp inhibitor. The intracellular concentration of kaempferol was significantly increased in the presence of N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918), a potent Bcrp inhibitor, suggesting that kaempferol may also be a Bcrp substrate. Moreover, in MDCK/Bcrp1 cells, the P-app,P- B-A of kaempferol was much higher (17.7 +/- 3.8 x 10(-6) cm/s) than the P-app,P- A-B (0.279 +/- 0.037 x 10(-6) cm/s), with a transport ratio of 63.4. In contrast, the transport ratio of kaempferol was only 0.68 in Bcrp1-negative MDCK/Mock cells. We report for the first time that kaempferol is a Bcrp substrate, and our results indicate that kaempferol inhibits Bcrp-mediated quercetin efflux. Intestinal efflux by Bcrp may represent one possible mechanism for the low bioavailability of kaempferol. The use of flavonoids in combination may increase their bioavailability through transport interactions.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 27 条
[1]   Current industrial practices of assessing permeability and P-glycoprotein interaction [J].
Balimane, PV ;
Han, YH ;
Chong, SH .
AAPS JOURNAL, 2006, 8 (01) :E1-E13
[2]   Metabolism, Oral Bioavailability and Pharmacokinetics of Chemopreventive Kaempferol in Rats [J].
Barve, Avantika ;
Chen, Chi ;
Hebbar, Vidya ;
Desiderio, Joseph ;
Saw, Constance Lay-Lay ;
Kong, Ah-Ng .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (07) :356-365
[3]  
Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
[4]   Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia [J].
Cho, Jae-Yong ;
Kim, In-Soo ;
Jang, Young-Ho ;
Kim, Ae-Ra ;
Lee, Seong-Ryong .
NEUROSCIENCE LETTERS, 2006, 404 (03) :330-335
[5]   Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters [J].
Choudhuri, Supratim ;
Klaassen, Curtis D. .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2006, 25 (04) :231-259
[6]   Tissue distribution of quercetin in rats and pigs [J].
de Boer, VCJ ;
Dihal, AA ;
van der Woude, H ;
Arts, ICW ;
Wolffram, S ;
Alink, GM ;
Rietjens, IMCM ;
Keijer, J ;
Hollman, PCH .
JOURNAL OF NUTRITION, 2005, 135 (07) :1718-1725
[7]   Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets [J].
deVries, JHM ;
Janssen, PLTMK ;
Hollman, PCH ;
vanStaveren, WA ;
Katan, MB .
CANCER LETTERS, 1997, 114 (1-2) :141-144
[8]   Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man [J].
Goh, LB ;
Spears, KJ ;
Yao, DG ;
Ayrton, A ;
Morgan, P ;
Wolf, CR ;
Friedberg, T .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (11) :1569-1578
[9]   DISPOSITION OF QUERCETIN IN MAN AFTER SINGLE ORAL AND INTRAVENOUS DOSES [J].
GUGLER, R ;
LESCHIK, M ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :229-234
[10]   The biochemistry and medical significance of the flavonoids [J].
Havsteen, BH .
PHARMACOLOGY & THERAPEUTICS, 2002, 96 (2-3) :67-202